CHICAGO, Nov. 22, 2016 /PRNewswire/ -- Esaote, one of the world leaders in the manufacturing of medical imaging equipment,
The MyLab™Six CrystaLine ultrasound system represents Esaote's latest technological innovation, focused on image quality enhancement, penetration and increased image detail and resolution. "MyLab™Six CrystaLine is the result of continual collaboration between Esaote's R&D team, Clinicians, and a broad network of Universities, to improve image formation and processing technologies, as well as design and workflow solutions," said Leonardo Forzoni, Esaote's Ultrasound Clinical Marketing Manager. "Difficult-to-scan patients are quite common in today's echo labs. The Esaote MyLab™Six CrystaLine upgrade addresses these challenges by offering better penetration, optimal image contrast, increased spatial resolution and less speckle artifacts. Detailed images are captured with overweight patients, providing clinical confidence even in very deep areas."
Productivity and Comfort
The MyLab™Six CrystaLine's cart-based compact design, features intuitive and easy to use workflow maximizing user comfort, and patient throughput. CrystaLine comes with a large selection of Esaote's appleprobe ergonomic transducers which provide a natural and comfortable operating position reducing risk of musculoskeletal stress and strain. The system features controls within easy reach, reduced distances from the trackball of the most used functions, short cuts, as well as macro recalling capabilities to automate frequent actions.
The intuitive system frees up operational time so healthcare professionals can focus on providing the best standard of care to their patients. The MyLab™Six CrystaLine's ergonomic workflow integrates the latest Esaote productivity solutions, including:
Massimo Rosa, Esaote's Chief Global Marketing Officer said "The MyLab™Six CrystaLine-powered engine represents a major improvement in all the clinical aspects relevant in diagnostic ultrasound scanning. With this system we want to offer our customers a solid and confident platform housed in a compact design which answers all their clinical needs."
Efficiency, Versatility and Value
The MyLab™Six CrystaLine is an adaptable and flexible ultrasound system in a variety of clinical settings, making it a premium choice within its class. The MyLab™Six CrystaLine maximizes efficiency in ultrasound scanning and offers improved diagnostic value through optimizing all aspects of signal transmission, starting from the echo generated by the patient's body up to the display on the system's monitor. The CrystaLine engine is fine-tuned with Esaote IQ probes to optimize penetration frequencies to derive maximum benefit from the energy delivered, allowing for better energy usage, and a higher level of diagnostic clarity. Wireless and wired connectivity offer data saving and transmission options. The Esaote MyLab™Six CrystaLine system is green; with reduced energy consumption for lower energy costs.
"Esaote has always been focused on developing innovations that improve diagnostic confidence with the clinician in mind," stated Glenn Davis, President of Esaote North America . "This new introduction increases the value proposition that Esaote brings to our customers and their patients."
Esaote will be exhibiting MyLab™Six CrystaLine at RSNA 2016. For more information please visit our online resources at www.esaote.com.
Esaote will be exhibiting at RSNA 2016, Chicago, November 27th – December 2nd 2016.Location: Booth #4103 – Hall A, South Building
For Press and Analyst Inquires Please Contact: Lisa Joos, Senior Director of Marketing at Esaote North America, Inc. at [email protected] or (650) 704-0698.
With €280.1 million consolidated sales in 2015 (of which 65% were generated from international markets), Esaote Group is a leading player in the biomedical equipment sector, with a particular focus on ultrasound, dedicated magnetic resonance, and software for managing the diagnostic process. Esaote has about 1,250 employees, 50% of whom are based outside of Italy. Esaote has manufacturing and research units in Italy and in the Netherlands. Esaote is internationally recognized as one of the "Top Ten" diagnostic imaging companies in the world and enjoys the co-operation of worldwide scientific and clinical research centers and universities. Esaote has filed more than120 international patents.
Information about the Esaote Group and its products is available at www.esaote.com.
Technology and features are system/configuration dependent. Specifications are subject to change without notice. Information might refer to products or modalities not yet approved in all countries. For further details, please contact your Esaote sales representative.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/esaote-launches-the-mylabsix-crystaline-at-rsna-2016---the-next-generation-of-its-multi-use-mylabsix-ultrasound-platform-combining-hardware-and-software-innovations-to-enhance-image-quality-increase-productivity-and-provide-fl-300367418.html
SOURCE Esaote North America
Subscribe to our Free Newsletters!
Sarcoma, is a cancer that may arise from several soft-tissues or bone. Treatment in early stages is ...
A wonder drug, soda bicarb or baking soda can be used for skin, teeth, hair, kidneys and much more ...
Melasma, also called as chloasma, is a skin hyperpigmentation problem characterized by brown spots ...View All